FDA drug approval is a full review process involving Phase IIII clinical trials, demonstrated safety and efficacy in humans, and post-market surveillance obligations
Before & After Observations Although large human trials are lacking, small case reports have appeared in alternative medicine journals
E., & Apostolakos, J
Despite five decades of research, its receptor and mechanism remain uncharacterised
available only through 503A compounding pharmacies under physician supervision Typical research dose range / 200-800 mcg/day subcutaneously, cycled 4-8 weeks Known lethal dose (LD50) / Not established in any species studied to date Rodent acute toxicity ceiling / No mortality observed at doses exceeding 10 mg/kg intraperitoneally Most reported excess-dose symptoms / Nausea, lightheadedness, flushing, injection-site irritation Organ toxicity at supratherapeutic doses / Not demonstrated in published preclinical literature Antidote availability / No specific antidote exists
NAD+: Cellular Energy & Longevity What it is: NAD+ (Nicotinamide Adenine Dinucleotide) is a vital molecule involved in cellular energy production and DNA repair
